Surgery for Lung Cancer: 356 Real Stories

356 stories match lung cancer and surgery. 177 of them mention chemotherapy.

Cancer Stories

A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

A uterine mass revealed a rare metastasis from lung adenocarcinoma

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: CK7-positive; TTF-1-positive; CK20-negative; PAX8-negative; GATA3-negative.

Metastatic Site: uterus within a leiomyoma

Twelve months after removal of the uterine metastasis, she remained well with normal surveillance imaging and no concern for recurrent disease.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Nivolumab-related adrenal failure during treatment for metastatic lung cancer

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: brain (left cerebellum)

Her confusion, gastrointestinal symptoms, and hyponatremia improved after glucocorticoid and mineralocorticoid replacement, and she was discharged on ongoing hormone replacement.

PubMed Central
OutcomeNot reported
Joyce, who was diagnosed with Lung CancerLung Cancer

Lung Cancer: Joyce's Survivor Story

Patient Info: Joyce Chisar, Female, 50s

Joyce was doing well after lung surgery, returned to work and completed a 5K while continuing broader treatment for her two cancers.

Cleveland Clinic
OutcomeCare Ongoing / Survivorship
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Osimertinib Improved Spinal Cord Metastases in Long-Standing Lung Cancer

Patient Info: Anonymized, Male, 50s | Stage IV

Biomarkers: Initial surgical specimen: no detected EGFR mutation and ALK-negative. Later pleural-fluid tumor: acquired EGFR T790M mutation with no other detected EGFR mutation.

Metastatic Site: cervical and mediastinal lymph nodes; bone; brain;…

Osimertinib improved neurologic function and kept the lung cancer stable for 14 months; he later died from bacterial pneumonia.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Pembrolizumab Produced a Complete Response but Multiple Immune Side Effects

Patient Info: Anonymized, Female, 70+

Biomarkers: PD-L1 expression 100%. Seronegative for acetylcholine-receptor and listed paraneoplastic antibodies during myasthenia-gravis evaluation.

Imaging showed a complete oncologic response that persisted for at least six months after pembrolizumab stopped, while the immune complications resolved after intensive treatment.

PubMed Central
OutcomeCancer-Free / NED
SA
Lung Cancer

Speech and Swallowing Support After Lung Cancer Relapse

Patient Info: Anonymized, 70+ | Stage Metastatic/Advanced

Metastatic Site: both lungs

The lung cancer relapsed with mediastinal and supraclavicular lymph-node involvement and metastases in both lungs. Ongoing speech and swallowing support prevented reported dysphagia complications.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Lung Cancer Treatment Complicated by Atezolizumab-Related Pneumonitis

Patient Info: Anonymized, Male, 70+

Biomarkers: EGFR mutation not detected; BRAF mutation not detected; ALK rearrangement not detected

The cancer progressed after chemoradiation. Atezolizumab was stopped because of pneumonitis, and he later began pemetrexed after a right adrenal mass became highly suspicious for malignancy.

PubMed Central
OutcomeSetback / Progression
A patient, who was diagnosed with Stage I Lung CancerLung Cancer

A Rare Airway Lung Cancer in a 31-Year-Old Woman

Patient Info: Anonymized, Female, Under 40 | Stage I

A 31-year-old non-smoker had a rare high-grade lung tumor that obstructed a bronchus after 2 years of cough, wheezing, and breathlessness.

PubMed Central
OutcomeNot reported
David, who was diagnosed with Lung CancerLung Cancer

Lung Cancer: David's Survivor Story

Patient Info: David Sherman, Male, 70+

All cancerous tissue was removed. David reported no pain or breathing difficulty after surgery, and doctors estimated a 90% 5-year survival chance.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Lung cancer presenting with brain and leptomeningeal spread

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: PD-L1 100%; EGFR negative; ALK rearrangement negative

Metastatic Site: brain, leptomeninges

His condition deteriorated within weeks of radiotherapy. He was readmitted with pneumonia and an acute right frontal brain haemorrhage and died within 1 week; metastatic lung adenocarcinoma was recorded as the cause of death.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Metastatic lung cancer causing recurrent small-bowel intussusception

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: EGFR mutation; exon 19 deletion in metastatic bowel lesions

Metastatic Site: small bowel

She recovered satisfactorily after bowel surgery, and care shifted to palliation with long-term nutritional support planned.

PubMed Central
OutcomeLiving With Cancer
A patient, who was diagnosed with Lung CancerLung Cancer

Typical lung carcinoid near the main airway treated with staged procedures and surgery

Patient Info: Anonymized, Male, Under 40

Biomarkers: Ki-67 2%; synaptophysin positive; chromogranin positive

After definitive surgery, the resection margins were clear and no postoperative chemotherapy or radiotherapy was recommended. He remained asymptomatic with surveillance CT and DOTATATE PET imaging planned.

PubMed Central
OutcomeCare Ongoing